Stock Earnings

Question 1

How did APLS's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Apellis Pharmaceuticals Inc is $1.67, beating expectations of $1.2.

Question 2

How did Apellis Pharmaceuticals Inc APLS's revenue perform in the last quarter?

Accepted Answer

Apellis Pharmaceuticals Inc revenue for the last quarter is $1.67

Question 3

What is the revenue estimate for Apellis Pharmaceuticals Inc?

Accepted Answer

According to 20 of Wall street analyst, the revenue estimate of Apellis Pharmaceuticals Inc range from $297.14M to $180.91M

Question 4

What's the earning quality score for Apellis Pharmaceuticals Inc?

Accepted Answer

Apellis Pharmaceuticals Inc has a earning quality score of B+/49.81852. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Apellis Pharmaceuticals Inc report earnings?

Accepted Answer

Apellis Pharmaceuticals Inc next earnings report is expected in 2026-01-28

Question 6

What are Apellis Pharmaceuticals Inc's expected earnings?

Accepted Answer

Apellis Pharmaceuticals Inc expected earnings is $414.81M, according to wall-street analysts.

Question 7

Did Apellis Pharmaceuticals Inc beat earnings expectations?

Accepted Answer

Apellis Pharmaceuticals Inc recent earnings of $458.57M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$1.2	$1.67	+39.16%	BEAT
Q2 '25	$-0.47	$-0.33	-29.78%	MISSED
Q1 '25	$-0.36	$-0.74	+105.55%	BEAT
Q4 '24	$-0.39	$-0.28	-28.2%	MISSED
Q3 '24	$-0.3	$-0.46	+53.33%	BEAT

Apellis Pharmaceuticals Inc (APLS) Price

APLS Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ